THE LIAISON GROUP, LLC

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$2.9M

Filings

130

Unique Clients

Active Period

2017–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$135,000	6	2
2025	$200,500	10	3
2024	$262,000	10	3
2023	$327,500	10	3
2022	$359,500	18	4
2021	$444,500	19	4
2020	$590,000	23	6
2019	$533,000	22	5
2018	$57,000	7	3
2017	$30,000	5	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
NATIONAL CANNABIS ROUNDTABLE	$1,972,500	32	2019–2025
PURA VIDA INVESTMENTS	$284,000	8	2019–2020
UNITED STATES CANNABIS ROUNDTABLE	$270,000	8	2025–2026
CALIFORNIA CANNABIS INDUSTRY ASSOCIATION	$257,000	21	2018–2023
ACREAGE HOLDINGS	$95,000	7	2018–2019
TOKKEN, INC.	$30,000	5	2017
OREGON CANNABIS ASSOCIATION	$25,000	11	2018–2020
ARIZONA DISPENSARIES ASSOCIATION	$5,500	10	2020–2022
CANNABIS BUSINESS ASSOCIATION OF ILLINOIS	—	18	2020–2024
CANNABIS FINNANCIAL INDUSTRY GROUP	—	10	2024–2026

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	99
SENATE	93
White House Office	15
Food & Drug Administration (FDA)	11
Alcohol & Tobacco Tax & Trade Bureau (TTB)	2
Treasury, Dept of	2

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Banking	Banking	100
Budget/Appropriations	Budget/Appropriations	52
Government Issues	Government Issues	40
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	31
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	25
Law Enforcement/Crime/Criminal Justice	Law Enforcement/Crime/Criminal Justice	17
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	16
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	6
Veterans	Veterans	2
Small Business	Small Business	1
Alcohol and Drug Abuse	Alcohol and Drug Abuse	1
Civil Rights/Civil Liberties	Civil Rights/Civil Liberties	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 7987119th Congress

CLIMB Act

2026 · third_quarter · Client: CANNABIS FINNANCIAL INDUSTRY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.

Client expense: — · Firm income: —

Matched citations: HR 7987

H.R. 9471119th Congress

SAFE Banking Act of 2026

2026 · third_quarter · Client: CANNABIS FINNANCIAL INDUSTRY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.

Client expense: — · Firm income: —

Matched citations: HR 9471

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2026 · third_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2026 · third_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

Show 21 more cited filings

H.R. 7024119th Congress

Hemp Planting Predictability Act

2026 · third_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Educating on dangers of unregulated intoxicating hemp products, and supporting efforts to close farm bill loophole Opposing HR. 7024 The Hemp Planting Predictability Act, Oppose amendments to delay closing of intoxicating hemp loophole

Client expense: — · Firm income: $45,000

Matched citations: HR. 7024

H.R. 7987119th Congress

CLIMB Act

2026 · third_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 7987

H.R. 9471119th Congress

SAFE Banking Act of 2026

2026 · third_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 9471

S. 471119th Congress

A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.

2026 · third_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: S. 471

H.R. 7987119th Congress

CLIMB Act

2026 · second_quarter · Client: CANNABIS FINNANCIAL INDUSTRY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.

Client expense: — · Firm income: —

Matched citations: HR 7987

H.R. 9471119th Congress

SAFE Banking Act of 2026

2026 · second_quarter · Client: CANNABIS FINNANCIAL INDUSTRY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.

Client expense: — · Firm income: —

Matched citations: HR 9471

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2026 · second_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2026 · second_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 7024119th Congress

Hemp Planting Predictability Act

2026 · second_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Educating on dangers of unregulated intoxicating hemp products, and supporting efforts to close farm bill loophole Opposing HR. 7024 The Hemp Planting Predictability Act, Oppose amendments to delay closing of intoxicating hemp loophole

Client expense: — · Firm income: $45,000

Matched citations: HR. 7024

H.R. 7987119th Congress

CLIMB Act

2026 · second_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 7987

H.R. 9471119th Congress

SAFE Banking Act of 2026

2026 · second_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Act (HR 9471)), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 9471

S. 471119th Congress

A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.

2026 · second_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: S. 471

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2026 · first_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills today include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Ac t(to be introduced in 119th Congress), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2026 · first_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 7024119th Congress

Hemp Planting Predictability Act

2026 · first_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Educating on dangers of unregulated intoxicating hemp products, and supporting efforts to close farm bill loophole Opposing HR. 7024 The Hemp Planting Predictability Act

Client expense: — · Firm income: $45,000

Matched citations: HR. 7024

H.R. 7987119th Congress

CLIMB Act

2026 · first_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills today include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Ac t(to be introduced in 119th Congress), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 7987

S. 471119th Congress

A bill to amend the Internal Revenue Code of 1986 to maintain the prohibition on allowing any deduction or credit associated with a trade or business involved in trafficking marijuana.

2026 · first_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: S. 471

H.R. 7987119th Congress

CLIMB Act

2026 · first_quarter · Client: CANNABIS FINNANCIAL INDUSTRY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act. The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.

Client expense: — · Firm income: —

Matched citations: HR 7987

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2025 · fourth_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Opposing the No Deductions for Marijuana Businesses Act (HR 1447, S. 471) Supporting efforts to remove application of Internal Revenue code 280(e)

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 1447119th Congress

No Deductions for Marijuana Businesses Act

2025 · fourth_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

USCR is advancing a legislative agenda that allows for (1) the rescheduling of cannabis from Schedule I to Schedule III on the Controlled Substances Act (2) states to set their own policies related to cannabis (2) allows for the safe banking and access to capital for the state-regulated cannabis industry (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills today include opposing HR 1447 the No Deductions for Marijuana Businesses Act, supporting the SAFE Banking Ac t(to be introduced in 119th Congress), and supporting the Veterans Equal Access Act. USCR supports other legislative initiatives that move towards ending federal cannabis prohibition including the States Act 2.0 and the Evidence Based Drug Policy Act

Client expense: — · Firm income: $45,000

Matched citations: HR 1447

H.R. 7024119th Congress

Hemp Planting Predictability Act

2025 · fourth_quarter · Client: UNITED STATES CANNABIS ROUNDTABLE

Open original LDA filing ↗

Cited source text and reported amounts

Educating on dangers of unregulated intoxicating hemp products, and supporting efforts to close farm bill loophole Opposing HR. 7024 The Hemp Planting Predictability Act

Client expense: — · Firm income: $45,000

Matched citations: HR. 7024

Source: Senate LDA

THE LIAISON GROUP, LLC — Lobbying Disclosure | Poliscope